A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | ENSC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $8.9 | $282.4 | 6% |
|
| Shares Out (Mil) | 13.0 | 54.0 | 24% |
|
| Institutional Ownership | 58.9% | 93.1% | 38% |
|
| Float (Mil) | 18.5 | 42.2 | 28% |
|
| Beta | 0.90 | 0.94 | 54% |
|
| Avg Daily Volume (000s) | 758 | 482 | 67% |
|
| Price Change (52-week) |
(78.8%) | 59.9% | 7% |
|
| Growth | ENSC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 5.5% | 14.1% | 39% |
|
| Net Income (5yr) | (153.2%) | (10.1%) | 1% |
|
| EPS (5yr) | na | 15.9% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | 1 | |
| Current EPS | ($0.190) | ($1.090) | ($0.050) | |
| Month Ago EPS | $0.090 | na | ($0.110) | |
| # Rev Up | 1 | 0 | na | |
| # Rev Down | 0 | 1 | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | (3.6%) | (72.6%) | na | |
| Financials | ENSC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5 | $37 | 5% |
|
| Net Income (TTM) (Mil) | ($13) | ($43) | 27% |
|
| EPS (TTM) | ($1.903) | ($1.500) | 15% |
|
| Operating Cash Flow (TTM) (Mil) | ($9) | ($31) | 21% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $7 | $190 | 6% |
|
| Valuation | ENSC | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.84 | na |
|
| P/E | na | 20.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | ENSC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (175.2%) | 66.9% | 1% |
|
| Net Margin | (280.5%) | (74.2%) | 3% |
|
| ROA | (295.9%) | (47.7%) | 1% |
|
| ROE | (968.3%) | (55.0%) | 0% |
|
| Liabilities to Assets | 137.6% | 29.8% | 97% |
|
| F-Score | 1 | 3 | 1% |
|
Ensysce Biosciences, Inc. did not pass any screens on 9/4/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
